Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

British Journal of Cancer

Volumn 81, Issue 8, 1999, Pages 1351-1355

  Mitry, E ^a,b   Baudin, E ^a   Ducreux, M ^a   Sabourin, J C ^a   Rufie P ^a   Aparicio, T ^a   Lasser, P ^a   Elias, D ^a   Duvillard, P ^a   Schlumberger, M ^a   Rougier, P ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Neuroendocrine carcinoma; Retrospective study; Treatment

Indexed keywords

CISPLATIN; ETOPOSIDE; OCTREOTIDE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; FEMALE; GASTROINTESTINAL SYMPTOM; HEARING LOSS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEPHROTOXICITY; NEUROENDOCRINE TUMOR; NEUROPATHY; NEUTROPENIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

EID: 0032734719     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690325     Document Type: Article

References (20)

1. Baudin E, Gigliotti A, Ducreux M, Ropers J, Comoy E, Sabourin JC, Bidart JM, Cailleux AF, Bonacci R, Ruffie P and Schlumberger M (1998) Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours. Br J Cancer 78: 1102-1107
2. Baudin E, Bidari JM, Rougier P, Lazar V, Ruffie P, Ropers J, Ducreux M, Troalen F, Sabourin JC, Comoy E, Lasser P, DeBaere T and Schlumberger M (1999) Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors. J Clin Endocrinol Metab 84: 69-75
3. Gould VE, Linnoila RI, Memoli VA and Warren WH (1983) Neuroendocrine cells and neuroendocrine neoplasms of the lung. Pathol Annu 18: 287-330
4. Greenberg RS, Baumgarten DA, Clark WS, Isacson P and McKeen K (1987) Prognostic factors for gastrointestinal and bronchopulmonary carcinoid tumors. Cancer 60: 2476-2483
5. Hainsworth JD, Johnson MH and Greco A (1988) Poorly differentiated neuroendocrine carcinoma of unknown primary site. Ann Intern Med 109: 364-371
6. Janson ET, Holmberg L, Stridsberg M, Eriksson B, Theodorsson E, Wilander E and Oberg K (1997) Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol 8: 685-690
7. Johnson LA, Lavin P, Moertel CG, Weiland L, Dayal Y, Doos WG, Geller SA, Cooper HS, Nime F, Masse S, Simson IW, Sumner H, Folsch E and Engstrom P (1983) Carcinoids: the association of histologic growth pattern and survival. Cancer 51: 882-889
8. Kaplan EL and Meier P (1958) Non-parametric estimation for incomplete observations. J Am Stat Assoc 53: 457-481
9. McDermott EW, Guduric B and Brennan MF (1994) Prognostic variables in patients with gastrointestinal carcinoid tumours. Br J Surg 81: 1007-1009
10. Mantel N and Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748
11. Miller AB, Hoogstraten B, Staquet M and Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207-214
12. Modlin IM and Sandor A (1997) An analysis of 8305 cases of carcinoid tumors. Cancer 79: 813-829
13. Moertel CG, Kvols LK, O'Connell MJ and Rubin J (1991) Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Cancer 68: 227-232
14. Oberg K (1994) Treatment of neuroendocrine tumors. Cancer Treat Rev 20: 331-355
15. Pelley RJ and Bukowski RM (1997) Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract. Curr Opin Oncol 9: 68-74
16. Rindi G, Bordi C, Rappel S, Larosa S, Stolte M and Solcia E (1996) Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior, World J Surg 20: 168-172
17. Seitz J, Perrier H, Giovannini M, Monges G, Fourdan O, Barrière N and Viens P (1995) Cancers neuroendocrines anaplasiques avancés: intérêt de l'association VP16-CDDP. Bull Cancer 82: 433
18. Staren ED, Gould VE, Warren WH, Wool NL, Bines S, Baker J, Bonomi P, Roseman DL and Economou SG (1988) Neuroendocrine carcinomas of the colon and rectum: a clinicopathologic evaluation. Surgery 104: 1080-1089
19. Warren WH, Faber LP and Gould VE (1989) Neuroendocrine neoplams of the lung: a clinicopathologic update. J Thorac Cardiovasc Surg 98: 321-332
20. Williams ED and Sandler M (1963) The classification of carcinoid tumors. Lancet 1: 238